Pharmacovigilance indicators: Desiderata for the future of medicine safety
Pharmacovigilance: Critique and Ways Forward, Page: 99-114
2016
- 1Citations
- 6Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
The thalidomide tragedy highlighted an unacceptable harm and potential risks of taking medicines [1]. This resulted in a global resolve that such a tragedy should never occur again, and all machinery to achieve this was put in place in the more developed countries in a rather systematic manner. This initial and prompt response ultimately resulted in the establishment of the WHO Programme for International Drug Monitoring (PIDM) schemes [2]. The initial focus was on suspected adverse drug reactions however over time the scope broadened to include other medicine-related problem. The occurrences regarding issues on medicinal safety after the thalidomide experience underscore the need for continuous watchfulness. The nomenclature has become more embracing and issues bordering on medicines safety coined “pharmacovigilance.".
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85018077987&origin=inward; http://dx.doi.org/10.1007/978-3-319-40400-4_10; http://link.springer.com/10.1007/978-3-319-40400-4_10; http://link.springer.com/content/pdf/10.1007/978-3-319-40400-4_10; https://dx.doi.org/10.1007/978-3-319-40400-4_10; https://link.springer.com/chapter/10.1007/978-3-319-40400-4_10
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know